Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ In Cell ELISA Kit

Product Description
The MaxDiscovery™ In Cell ELISA Kit is an enzyme immunoassay for quantitative protein analysis directly in adherent cell cultures—there is no need to lyse cells or run protein gels. The technique can be thought of as an ELISA performed on fixed, permeablized cells rather than on immobilized antigen. Like most ELISA assays, protein is detected using a series of two antibodies, a primary antibody for the protein of interest (not provided with the kit) and an enzyme-conjugated secondary antibody. The protein:antibody complex is visualized by adding an enzyme substrate that, when catalyzed, changes the color of the assay solution within the well of the tissue culture plate so that it can be read in a spectrophotometer at 450 nm. The relative amount of protein in the cells will be directly proportional to the amount of signal that is obtained, making this a simple, convenient, and accurate technique for quantifying specific protein levels within cell lines. The MaxDiscovery™ In Cell ELISA Kit contains materials for washing, fixing, and permeablizing cells in culture. HRP-conjugated anti-mouse and anti-rabbit secondary antibodies are included in the kit so that user-supplied primary antibodies from either mouse or rabbit may be used for detection of the protein of interest. In addition, the kit includes mouse-derived antibody targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH is one of the key enzymes involved in glycolysis, and because of its high-level, and constitutive expression, it is widely used as a loading control for Northern/Western blots and for protein normalization. The quantity of GAPDH in a sample is directly proportional to the number of cells in the sample. GAPDH expression is often used as an internal control in gene expression studies. Typically, GAPDH expression is used to normalize expression signal from the gene-of-interest with respect to cell number. This has been particularly useful for RNAi studies or other drug treatment studies. The MaxDiscovery™ In Cell ELISA assay makes it easy to quickly measure levels of GAPDH (positive control) or your protein-of-interest directly in cultured cells for relative quantitative analysis.
Product MaxDiscovery™ In Cell ELISA Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 3440-02
Quantity 2 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Fly Study into Therapies for HVP-Induced Cancer
Fruit flies may help scientists understand the mechanism by which HPV can cause cancer as well as identify potential drug treatments.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
'Missing Evolutionary Link' of Natural Drug Source Found
Scripps Florida study finds 'missing evolutionary link' of a widely used natural drug source
Grad Student's Finding Enables Rapid Compound Screening
Grad student makes technical leap that could enable rapid screening of anti-cancer compounds.
Uncovering Constructor Proteins
Scientists have discovered a new bacterial cell wall builder that could be a target for antibiotic development.
Cholesterol Linked to Aggressive Cancers
Research suggests fats, such as cholesterol, can increase aggressive cancer progression.
Biomarker Breakthrough Could Improve Parkinson’s Treatment
A new method of tracking Parkinson's progression could aid evaluation of new and experimental treatments to slow or stop the disease.
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
How Parkinson’s Disease Alters Brain Activity Over Time
The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!